Bouros D - Search Results

1

Stem cell therapy in pulmonary fibrosis.

Tzouvelekis A, Antoniadis A, Bouros D. Tzouvelekis A, et al. Among authors: bouros d. Curr Opin Pulm Med. 2011 Sep;17(5):368-73. doi: 10.1097/MCP.0b013e328348744f. Curr Opin Pulm Med. 2011. PMID: 21681099 Review.

2

Association of malignancy with diseases causing interstitial pulmonary changes.

Bouros D, Hatzakis K, Labrakis H, Zeibecoglou K. Bouros D, et al. Chest. 2002 Apr;121(4):1278-89. doi: 10.1378/chest.121.4.1278. Chest. 2002. PMID: 11948064 Review.

3

Interferons and their application in the diseases of the lung.

Antoniou KM, Ferdoutsis E, Bouros D. Antoniou KM, et al. Among authors: bouros d. Chest. 2003 Jan;123(1):209-16. doi: 10.1378/chest.123.1.209. Chest. 2003. PMID: 12527624 Review.

4

Effects of formoterol and salmeterol on resting inspiratory capacity in COPD patients with poor FEV(1) reversibility.

Bouros D, Kottakis J, Le Gros V, Overend T, Della Cioppa G, Siafakas N. Bouros D, et al. Curr Med Res Opin. 2004 May;20(5):581-6. doi: 10.1185/030079904125003368. Curr Med Res Opin. 2004. PMID: 15140323 Clinical Trial.

5

Th1 cytokine pattern (IL-12 and IL-18) in bronchoalveolar lavage fluid (BALF) before and after treatment with interferon gamma-1b (IFN-gamma-1b) or colchicine in patients with idiopathic pulmonary fibrosis (IPF/UIP).

Antoniou KM, Alexandrakis MG, Sfiridaki K, Tsiligianni I, Perisinakis K, Tzortzaki EG, Siafakas NM, Bouros DE. Antoniou KM, et al. Sarcoidosis Vasc Diffuse Lung Dis. 2004 Jun;21(2):105-10. Sarcoidosis Vasc Diffuse Lung Dis. 2004. PMID: 15281431 Clinical Trial.

6

The clinical significance of serum and bronchoalveolar lavage inflammatory cytokines in patients at risk for Acute Respiratory Distress Syndrome.

Bouros D, Alexandrakis MG, Antoniou KM, Agouridakis P, Pneumatikos I, Anevlavis S, Pataka A, Patlakas G, Karkavitsas N, Kyriakou D. Bouros D, et al. BMC Pulm Med. 2004 Aug 17;4:6. doi: 10.1186/1471-2466-4-6. BMC Pulm Med. 2004. PMID: 15315713 Free PMC article.

7

Use of interrupter technique in assessment of bronchial responsiveness in normal subjects.

Panagou P, Kottakis I, Tzouvelekis A, Anevlavis S, Bouros D. Panagou P, et al. Among authors: bouros d. BMC Pulm Med. 2004 Nov 12;4:11. doi: 10.1186/1471-2466-4-11. BMC Pulm Med. 2004. PMID: 15541173 Free PMC article.

8

Application of microarray technology in pulmonary diseases.

Tzouvelekis A, Patlakas G, Bouros D. Tzouvelekis A, et al. Among authors: bouros d. Respir Res. 2004 Dec 7;5(1):26. doi: 10.1186/1465-9921-5-26. Respir Res. 2004. PMID: 15585067 Free PMC article. Review.

9

Expression of apoptotic and antiapoptotic markers in epithelial cells in idiopathic pulmonary fibrosis.

Plataki M, Koutsopoulos AV, Darivianaki K, Delides G, Siafakas NM, Bouros D. Plataki M, et al. Among authors: bouros d. Chest. 2005 Jan;127(1):266-74. doi: 10.1378/chest.127.1.266. Chest. 2005. PMID: 15653994

10

Induced sputum versus bronchoalveolar lavage fluid in the evaluation of patients with idiopathic pulmonary fibrosis.

Antoniou KM, Alexandrakis M, Tzanakis N, Tsiligianni I, Tzortzaki EG, Siafakas NM, Bouros DE. Antoniou KM, et al. Respiration. 2005 Jan-Feb;72(1):32-8. doi: 10.1159/000083398. Respiration. 2005. PMID: 15753632

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results